Table 2.
Relationships between the expression of ADAMDEC1 and clinicopathological parameters
| Age | |||||
| <70 y (n = 157) | ≥70 y (n = 16) | P value | |||
| IHC score | 36.1±34.6 | 22.8±15.9 | 0.010 | ||
| Gender | |||||
| Female | Male | P value | |||
| IHC score | 32.6±32.6 | 36.7±34.0 | 0.424 | ||
| Stage | |||||
| I | II | III | IV | P value | |
| IHC score | 73.8±53.1 | 39.8±32.1 | 25.6±25.0 | 27.6±29.3 | 0.000 |
| Differentiation of cancer cells | |||||
| W/D | M/D | P/D | P value | ||
| IHC score | 49.4±45.0 | 34.4±31.5 | 20.5±23.8 | 0.021 | |
| Depth of tumor invasion (T stage) | |||||
| 1 | 2 | 3 | 4 | P value | |
| IHC score | 83.0±61.7 | 52.7±46.3 | 32.7±29.5 | 19.7±30.0 | 0.001 |
| Nodal metastasis (N stage) | |||||
| Absent | Low (1-3) | High (≥4) | P value | ||
| IHC score | 44.8±38.1 | 27.2±24.3 | 25.6±27.9 | 0.001 | |
| Distant metastasis | |||||
| Negative | Positive | P value | |||
| IHC score | 38.1±35.0 | 24.0±26.4 | 0.037 | ||
| Perineural tumor invasion | |||||
| Negative | Positive | P value | |||
| IHC score | 37.8±34.8 | 17.1±14.1 | 0.000 | ||
| Tumor budding | |||||
| Absent | Low (5-9/10HPF) | High | P value | ||
| IHC score | 41.1±34.4 | 33.1±29.9 | 19.2±24.4 | 0.027 | |
IHC, immunohistochemistry.